These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20861124)

  • 1. Familial glucocorticoid resistance caused by a novel frameshift glucocorticoid receptor mutation.
    Trebble P; Matthews L; Blaikley J; Wayte AW; Black GC; Wilton A; Ray DW
    J Clin Endocrinol Metab; 2010 Dec; 95(12):E490-9. PubMed ID: 20861124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance.
    Ruiz M; Lind U; Gåfvels M; Eggertsen G; Carlstedt-Duke J; Nilsson L; Holtmann M; Stierna P; Wikström AC; Werner S
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):363-71. PubMed ID: 11589680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.
    Vottero A; Kino T; Combe H; Lecomte P; Chrousos GP
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene.
    Karl M; Lamberts SW; Detera-Wadleigh SD; Encio IJ; Stratakis CA; Hurley DM; Accili D; Chrousos GP
    J Clin Endocrinol Metab; 1993 Mar; 76(3):683-9. PubMed ID: 8445027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five patients with biochemical and/or clinical generalized glucocorticoid resistance without alterations in the glucocorticoid receptor gene.
    Huizenga NA; de Lange P; Koper JW; de Herder WW; Abs R; Kasteren JH; de Jong FH; Lamberts SW
    J Clin Endocrinol Metab; 2000 May; 85(5):2076-81. PubMed ID: 10843199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene.
    Mendonca BB; Leite MV; de Castro M; Kino T; Elias LL; Bachega TA; Arnhold IJ; Chrousos GP; Latronico AC
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1805-9. PubMed ID: 11932321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity.
    Charmandari E; Raji A; Kino T; Ichijo T; Tiulpakov A; Zachman K; Chrousos GP
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3696-705. PubMed ID: 15769988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial glucocorticoid receptor haploinsufficiency by non-sense mediated mRNA decay, adrenal hyperplasia and apparent mineralocorticoid excess.
    Bouligand J; Delemer B; Hecart AC; Meduri G; Viengchareun S; Amazit L; Trabado S; Fève B; Guiochon-Mantel A; Young J; Lombès M
    PLoS One; 2010 Oct; 5(10):e13563. PubMed ID: 21042587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel point mutation in helix 10 of the human glucocorticoid receptor causes generalized glucocorticoid resistance by disrupting the structure of the ligand-binding domain.
    Nader N; Bachrach BE; Hurt DE; Gajula S; Pittman A; Lescher R; Kino T
    J Clin Endocrinol Metab; 2010 May; 95(5):2281-5. PubMed ID: 20335448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticosteroid resistance in humans. Elucidation of the molecular mechanisms and implications for pathophysiology.
    Stratakis CA; Karl M; Schulte HM; Chrousos GP
    Ann N Y Acad Sci; 1994 Nov; 746():362-74; discussion 374-6. PubMed ID: 7825890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalized glucocorticoid resistance caused by a novel two-nucleotide deletion in the hormone-binding domain of the glucocorticoid receptor gene NR3C1.
    Donner KM; Hiltunen TP; Jänne OA; Sane T; Kontula K
    Eur J Endocrinol; 2013 Jan; 168(1):K9-K18. PubMed ID: 23076843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms.
    Charmandari E; Kino T; Chrousos GP
    Ann N Y Acad Sci; 2004 Jun; 1024():168-81. PubMed ID: 15265781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking.
    Kino T; Stauber RH; Resau JH; Pavlakis GN; Chrousos GP
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5600-8. PubMed ID: 11701741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype.
    Charmandari E; Kino T; Souvatzoglou E; Vottero A; Bhattacharyya N; Chrousos GP
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1939-49. PubMed ID: 15070967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid resistance in premature pubarche and adolescent hyperandrogenism.
    Witchel SF; Smith RR
    Mol Genet Metab; 1999 Feb; 66(2):137-41. PubMed ID: 10068517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N363S and I559N single nucleotide polymorphisms of the h-GR/NR3C1 gene in patients with bronchial asthma.
    Panek M; Pietras T; Antczak A; Fabijan A; Przemęcka M; Górski P; Kuna P; Szemraj J
    Int J Mol Med; 2012 Jul; 30(1):142-50. PubMed ID: 22469783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization of human glucocorticoid receptor mutants, R477H and G679S, associated with primary generalized glucocorticoid resistance.
    Ruiz M; Hedman E; Gåfvels M; Eggertsen G; Werner S; Wahrenberg H; Wikström AC
    Scand J Clin Lab Invest; 2013 Apr; 73(3):203-7. PubMed ID: 23391271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GRKO mice express an aberrant dexamethasone-binding glucocorticoid receptor, but are profoundly glucocorticoid resistant.
    Cole TJ; Myles K; Purton JF; Brereton PS; Solomon NM; Godfrey DI; Funder JW
    Mol Cell Endocrinol; 2001 Feb; 173(1-2):193-202. PubMed ID: 11223190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant and wild-type androgen receptors exhibit cross-talk on androgen-, glucocorticoid-, and progesterone-mediated transcription.
    Yen PM; Liu Y; Palvimo JJ; Trifiro M; Whang J; Pinsky L; Jänne OA; Chin WW
    Mol Endocrinol; 1997 Feb; 11(2):162-71. PubMed ID: 9013763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hotspot in the glucocorticoid receptor DNA-binding domain susceptible to loss of function mutation.
    Banuelos J; Shin SC; Lu NZ
    Steroids; 2015 Apr; 96():115-20. PubMed ID: 25676786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.